Exicure XCUR
NASDAQ XCUR
$1.15 -0.15 (-11.54%)
As of: Aug 21, 2026 · 3:59 PM EDT

Exicure (XCUR) Liabilities and Shareholders Equity (2016 - 2026)

Exicure's (XCUR) quarterly Liabilities and Shareholders Equity came in at $12.8 million in Q1 2026, down 38.32% YoY from $20.7 million in Q1 2025, and down 9.16% on a QoQ basis from $14.0 million in Q4 2025.

Exicure (XCUR) Liabilities and Shareholders Equity (2016 - 2026) Analysis & Trends

Exicure (XCUR) has 11 years of Liabilities and Shareholders Equity data on file, last reported at $12.8 million in Q1 2026.

  • Quarterly Liabilities and Shareholders Equity fell 38.32% year-over-year to $12.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $60.8 million (up 6.57% YoY) and the FY2025 annual result came in at $14.0 million, down 6.74% from the prior year.
  • Liabilities and Shareholders Equity slipped to $12.8 million in Q1 2026, from $14.0 million in the prior quarter.
  • In the past five years, Liabilities and Shareholders Equity ranged from a high of $41.9 million in Q1 2022 to a low of $10.6 million in Q3 2024.
  • A 5-year average of $19.2 million and a median of $15.3 million in 2025 frame the typical range for Liabilities and Shareholders Equity.
  • Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity slumped 64.04% — and 2025, when it surged 93.07%.
  • Tracing XCUR's Liabilities and Shareholders Equity over 5 years: stood at $23.3 million in 2022, then sank by 50.36% to $11.6 million in 2023, then jumped by 30.02% to $15.1 million in 2024, then decreased by 6.74% to $14.0 million in 2025, then declined by 9.16% to $12.8 million in 2026.
  • The last three Liabilities and Shareholders Equity figures came in at $12.8 million (Q1 2026), $14.0 million (Q4 2025), and $15.3 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Liabilities and Shareholders Equity (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 27.42 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 41.73 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 10.03 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 10.96 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 9.18 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 5.56 Bn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 25.60 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 2.10 Bn
9 Royalty Pharma 27.27 Bn 26.43 Bn - 19.82 Bn
10 Exicure 7.27 Mn 7.27 Mn - 11.40 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 12.76 Mn
Dec 31, 2025 14.04 Mn
Sep 30, 2025 15.27 Mn
Jun 30, 2025 18.74 Mn
Mar 31, 2025 20.68 Mn
Dec 31, 2024 15.06 Mn
Sep 30, 2024 10.63 Mn
Jun 30, 2024 10.69 Mn
Mar 31, 2024 10.71 Mn
Dec 31, 2023 11.58 Mn
Sep 30, 2023 12.95 Mn
Jun 30, 2023 17.56 Mn
Mar 31, 2023 23.94 Mn
Dec 31, 2022 23.33 Mn
Sep 30, 2022 28.94 Mn
Jun 30, 2022 36.96 Mn
Mar 31, 2022 41.90 Mn
Dec 31, 2021 64.87 Mn
Sep 30, 2021 77.90 Mn
Jun 30, 2021 74.47 Mn